Log In
BCIQ
Print this Print this
 

INCB39110

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
DescriptionJanus kinase-1 (JAK-1) inhibitor
Molecular Target Janus kinase-1 (JAK-1)
Mechanism of ActionJanus kinase-1 (JAK-1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/11/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today